Who
Stacy Lindborg
President and CEO
Company insider
Files Form 4 as: President and CEO, Imunon; Co-Chief Executive Officer, Brainstorm Cell Therapeutics.
In numbers
- Trades disclosed
- 50
- Buys
- 2
- Sells
- 0
- Bought
- $45K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 1 Jun 2020
- Last trade
- 9 Oct 2026
- Last filed
- 13 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Oct 2026filed 13 Oct 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $3,2152,977 at $1.08 | filing |
| 25 Sep 2026filed 28 Sep 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $9,4436,697 at $1.41 | filing |
| 25 Sep 2026filed 28 Sep 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $9,4436,697 at $1.41 | filing |
| 11 Sep 2026filed 15 Sep 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $8,0915,504 at $1.47 | filing |
| 11 Sep 2026filed 15 Sep 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $8,0915,504 at $1.47 | filing |
| 28 Aug 2026filed 1 Sep 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $11K6,822 at $1.60 | filing |
| 28 Aug 2026filed 1 Sep 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $11K6,822 at $1.60 | filing |
| 14 Aug 2026filed 17 Aug 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $11K6,615 at $1.65 | filing |
| 14 Aug 2026filed 17 Aug 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $11K6,615 at $1.65 | filing |
| 31 Jul 2026filed 4 Aug 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $7,9665,010 at $1.59 | filing |
| 31 Jul 2026filed 4 Aug 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $7,9665,010 at $1.59 | filing |
| 17 Jul 2026filed 21 Jul 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $8,9804,907 at $1.83 | filing |
| 17 Jul 2026filed 21 Jul 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $8,9804,907 at $1.83 | filing |
| 2 Jul 2026filed 7 Jul 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $4,8402,534 at $1.91 | filing |
| 2 Jul 2026filed 7 Jul 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $4,8402,534 at $1.91 | filing |
| 25 Jun 2026filed 29 Jun 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $115K67,150 at $1.72 | filing |
| 25 Jun 2026filed 29 Jun 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $115K67,150 at $1.72 | filing |
| 18 Jun 2026filed 23 Jun 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $3,2811,803 at $1.82 | filing |
| 18 Jun 2026filed 23 Jun 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $3,2811,803 at $1.82 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $3,2821,593 at $2.06 | filing |
News
IMUNON To Sell ThermoDox Rights To VoxelDox For Glioblastoma MultiformeIMNN · rttnews.com · 21 Oct 2026
0 headlines in the last 90 days name Stacy Lindborg; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.